Philip James Wealth Mangement, LLC Gilead Sciences, Inc. Transaction History
Philip James Wealth Mangement, LLC
- $774 Billion
- Q4 2024
A detailed history of Philip James Wealth Mangement, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Philip James Wealth Mangement, LLC holds 49,529 shares of GILD stock, worth $4.8 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
49,529
Previous 52,291
5.28%
Holding current value
$4.8 Million
Previous $4.38 Billion
4.35%
% of portfolio
0.59%
Previous 0.54%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
1,959Shares Held
993MCall Options Held
10.5MPut Options Held
9.86M-
Black Rock Inc. New York, NY121MShares$11.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$11.2 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.42 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.99 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.83 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $122B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...